AIV Logo AIV Assistant

 Logo Aarti Drugs Limited - AARTIDRUGS.NS 438.40 INR

P/E
23.05
EPS
18.34
Yield
0.24%
P/B
3.02
Beta
0.48

438.400 INR

438.400 INR

Daily: +4.72%
Key Metrics

P/E: 23.05

EPS: 18.34

Book Value: 139.96

Price to Book: 3.02

Debt/Equity: 46.18

% Insiders: 60.609%

Growth

Revenue Growth: -0.08%

Earnings Growth: 0.02%

Estimates

Forward P/E: 14.95

Dividend

Dividend Yield: 0.24%

Annual dividends: 1.00 INR

Ex-Div. Date: Feb. 4, 2025

 Logo About Aarti Drugs Limited - (AARTIDRUGS.NS)

Country: India

Sector: Health Care

Website: http://www.aartidrugs.co.in

Aarti Drugs Limited, through its subsidiaries, manufactures and markets active pharmaceutical ingredients (APIs), pharmaceutical intermediates, specialty chemicals, and formulations in India and internationally. The company offers aceclofenac, celecoxib, diclofenac sodium, diclodenac potassium, diclofenac diethylamine, diclofenac resinate, diclofenac epolamine, nimesulide, ciprofloxacin HCL, enrofloxacin base, gatifloxacin sesquihydrate, levofloxacin base, moxifloxacin, norfloxacin, ofloxacin, metronidazole benzoate, ornidazole, secnidazole, tinidazole, clopidogrel bisulphate, ticlopidine HCL, metformin HCL, pioglitazone HCL, teneligliptin, vildagliptin, fluconazole, ketoconazole, tolnaftate, zolpidem tartrate, niacin, raloxifene HCL, and acamprosate. It also provides benzene sulphonyl chloride, benzene sulphonic acid, benzene sulphonic acid methyl ester, sodium benzene sulfinate, para toluene sulphonyl chloride, methyl para toluenesulfonate, sodium para toluenesulfinate, para chlorobenzenesulfonyl chloride, formamide, calcium fluoride, potasium formate, benzenesulfonamide, ethyl p- toluenesulfonate, N,N',N'-tris-(4-toluene sulfonyl)-diethylenetriamine, ortho para toluene sulfonamides, ortho para toluene sulfonamides acid methyl ester, para chlorobenznesulfonamide, para toluenesulfonyl hydrazide, para toluenesulfonamide, and sodium benzenesulfonate. In addition, it offers pharma intermediate products, which includes Celecoxib, Ciprofloxacin, Clopidogrel, Diclofenac, Ketoconazole, Nimesulide, Raloxifene, Tinidazole, and Zolpidem. Further, the company develops drugs for the antioxidant, antifungal, cardiovascular, and antidiabetic therapeutic areas. The company was incorporated in 1984 and is headquartered in Mumbai, India.

Exchange Ticker
NSI (India) AARTIDRUGS.NS
Dividend Yield

0.24%

Annual Dividends

1.00 INR

Next ex. div date

Feb. 4, 2025

Historical Dividends
Year Total Dividends
2026 1.00 INR
2025 1.00 INR
2024 1.00 INR
2023 1.00 INR
2022 1.00 INR
2020 3.00 INR
2019 0.25 INR
2018 1.25 INR
2017 0.25 INR
2016 1.13 INR
2015 1.94 INR
2014 1.88 INR
2013 1.25 INR
2012 1.00 INR
2011 0.63 INR
2010 0.63 INR
2009 0.38 INR
2008 0.23 INR
2007 0.15 INR
2006 0.19 INR
2005 0.20 INR
2004 0.40 INR
2003 0.15 INR

Yearly aggregated dividends

Dividends

Aarti Drugs Limited
Feb 28, 2025 Paid
Dividend
1.0 INR

Historical Split Corporate Actions

Trades
My Trades
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion